Single-cell eQTL mapping identifies cell type-specific genetic control of autoimmune disease

Prior research has shown that the human immune system displays substantial variation between individuals, which directly influences susceptibility to various autoimmune conditions. This interindividual diversity stems from a complex interplay between environmental factors and inherited genetic variants that regulate gene expression. While bulk transcriptomic studies have identified numerous associations, they often fail to capture the nuances of cell type-specific regulation within heterogeneous tissues. Understanding the precise mechanisms by which common alleles drive phenotypic diversity in immune responses remains a significant challenge in modern genomics and personalized medicine. The lack of high-resolution data has hindered the ability to map regulatory variants to specific cellular lineages or transient activation states. Existing datasets frequently overlook the dynamic nature of genetic control during cellular differentiation and maturation processes. This absence of evidence motivated the current investigation into the genetic control of gene expression at single-cell resolution.

This investigation characterizes the genetic architecture of gene expression across diverse immune cell populations using high-throughput single-cell RNA sequencing (scRNA-seq) technologies. The researchers sought to map expression quantitative trait loci (eQTLs) within a large cohort of nearly one thousand healthy human subjects to identify regulatory variants. By analyzing over one million individual cells, the team aimed to identify both local and distant regulatory variants that govern transcriptomic profiles in specific lineages. The study evaluates how these genetic associations shift during dynamic cellular transitions, specifically focusing on the maturation of B cells from naïve to memory states. Another primary objective involves pinpointing the specific causal pathways through which known risk variants contribute to clinical autoimmune pathology at the cellular level. The project integrates the fields of genetic epidemiology and transcriptomics to explain the drivers of interindividual variation in human immune function. This research provides a framework for understanding how common genetic variation translates into functional differences in immune cell behavior.

The researchers utilized single-cell RNA sequencing (scRNA-seq) to profile 1,267,758 peripheral blood mononuclear cells (PBMCs) collected from a cohort of 982 healthy human subjects. This massive dataset allowed for the high-resolution mapping of regulatory variants across 14 distinct immune cell types identified through computational clustering. The analytical pipeline identified 26,597 independent cis-expression quantitative trait loci (cis-eQTLs) and 990 trans-eQTLs by correlating genotype data with single-cell transcriptomes. To assess the impact of cellular differentiation, the team modeled dynamic allelic effects in B cells as they transitioned from naïve to memory states. A Mendelian randomization approach was subsequently employed to identify the causal routes by which 305 risk loci contribute to disease at the cellular level. This integrated framework allowed for the systematic mapping of genetic variants to specific cellular phenotypes and regulatory networks within the immune system. The study employed rigorous statistical controls to ensure the accuracy and reproducibility of the identified genetic associations across the large participant cohort.

The analysis identified 26,597 independent cis-expression quantitative trait loci (cis-eQTLs) and 990 trans-eQTLs across the 14 examined peripheral blood mononuclear cell (PBMC) populations. Most of these regulatory variants exhibited effects that were highly specific to particular cell types rather than being shared across all immune lineages. In B cells, the researchers observed dynamic allelic influences as the cells progressed from a naïve state to a memory state during maturation. The data demonstrate that commonly segregating alleles are responsible for significant interindividual variation in human immune function and gene expression levels. Using Mendelian randomization, the study successfully mapped the causal pathways for 305 risk loci associated with various autoimmune diseases to specific cell types. These findings highlight the functional importance of cell-type context in understanding the genetic basis of complex human traits and disease susceptibility. The results provide a detailed map of how genetic variation influences the transcriptomic landscape of the human immune system at single-cell resolution.

This comprehensive map provides a foundational resource for understanding the genetic regulation of the human immune system at an unprecedented level of resolution. The results suggest that most genetic risk for autoimmune conditions operates through cell type-specific regulatory mechanisms rather than global expression changes. Future research can leverage these single-cell eQTL datasets to refine therapeutic targets for a wide range of inflammatory and autoimmune disorders. The integration of single-cell RNA sequencing (scRNA-seq) with genetic epidemiology offers a powerful strategy for uncovering the drivers of phenotypic diversity in humans. These insights may eventually lead to more personalized approaches in clinical immunology by accounting for individual genetic backgrounds and cellular profiles. The study underscores the necessity of high-resolution transcriptomics in deciphering the functional consequences of non-coding genetic variation in diverse human populations. The researchers conclude that identifying these cellular drivers is essential for translating genetic associations into actionable clinical knowledge for autoimmune disease management.